X @Bloomberg
Today in Bloomberg Deals: DCC says yes to KKR and ECP, Argenx expands in immunology and Brown-Forman rejects Sazerac. https://t.co/dqHmspTVjA ...
Today in Bloomberg Deals: DCC says yes to KKR and ECP, Argenx expands in immunology and Brown-Forman rejects Sazerac. https://t.co/dqHmspTVjA ...